Ana Maria Rivas-Grajales, MD
Assistant Professor
Boston University Chobanian & Avedisian School of Medicine
Dept of Psychiatry

MD, Universidad Del Valle
MSc, University College London (UCL)



Dr. Ana Maria Rivas-Grajales is a Neuropsychiatrist and Assistant Professor in the Department of Psychiatry at Boston University School of Medicine. She directs the Neuropsychiatry and Neuromodulation Service at Boston Medical Center. Dr. Rivas-Grajales completed residency training in psychiatry at Baylor College of Medicine where she served as chief resident of research, and a clinical fellowship in Behavioral Neurology and Neuropsychiatry at Massachusetts General Hospital.

Her clinical interests include treatment-resistant depression, neuropsychiatry of Parkinson’s disease, epilepsy, multiple sclerosis, and traumatic brain injury; functional neurological disorders, and early onset dementia. Her research focuses on the understanding of the mechanism of action of neuromodulation therapies for treatment-resistant depression.

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Molton IR, Keatley E, Jaywant A, Josephy-Hernandez S, Rivas-Grajales AM, Perez DL, Mukherjee D. Ethical issues in the treatment of functional neurological disorder. PM R. 2022 01; 14(1):112-119. PMID: 34958180
     
  2. Rivas-Grajales AM, Mathew SJ, Rodgers JJ. A Case of Intranasal Ketamine Misuse: Considerations for Clinical Practice. J Psychiatr Pract. 2021 11 05; 27(6):492-495. PMID: 34768275
     
  3. Rivas-Grajales AM, Salas R, Robinson ME, Qi K, Murrough JW, Mathew SJ. Habenula Connectivity and Intravenous Ketamine in Treatment-Resistant Depression. Int J Neuropsychopharmacol. 2021 05 18; 24(5):383-391. PMID: 33249434; PMCID: PMC8130203; DOI: 10.1093/ijnp/pyaa089;
     
  4. Schanzer B, Rivas-Grajales AM, Khan A, Mathew SJ. Novel investigational therapeutics for generalized anxiety disorder (GAD). Expert Opin Investig Drugs. 2019 Nov; 28(11):1003-1012. PMID: 31607187
     
  5. Mathew SJ, Rivas-Grajales AM. "Does the opioid system block or enhance the antidepressant effects of ketamine?" Chronic Stress (Thousand Oaks). 2019 Jan-Dec/; 3. PMID: 31276079; PMCID: PMC6604658; DOI: 10.1177/2470547019852073;
     
  6. Kanner AM, Rivas-Grajales AM. Psychosis of epilepsy: a multifaceted neuropsychiatric disorder. CNS Spectr. 2016 Jun; 21(3):247-57. PMID: 27322691
     

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 6 publications over 4 distinct years, with a maximum of 2 publications in 2019 and 2021

YearPublications
20161
20192
20212
20221

Contact for Mentoring:

771 Albany St
Boston MA 02118
Google Map


Rivas-Grajales's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Similar People
_
Same Department